MyCARe: A Model to Predict Outcomes after CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma

Nico Gagelmann

February 15, 2024


Presentations

Choosing the optimal unrelated donor - Katharina Fleischhauer

Immunogenetics of relapse - Effie Petersdorf

The impact of classical and non-classical UHR HLA typing and matching on unrelated donor HCT outcomes - Neema Mayor

Featured presentations

Document

Choosing the optimal unrelated donor

Katharina Fleischhauer

April 15, 2024

Document

Immunogenetics of relapse

Effie Petersdorf

April 15, 2024